Family Practice NewsWhat difference would an empagliflozin CVD indication make?July 7, 2016DiabetesEndocrinology
Family Practice NewsFDA panel narrowly endorses empagliflozin’s cardiovascular mortality benefitJune 29, 2016CardiologyGeriatricsDiabetesEndocrinology
Family Practice NewsNovel vaccine scores better hepatitis B seroprotection in type 2 diabetesJune 29, 2016DiabetesEndocrinologyGastroenterologyInfectious DiseasesVaccines
The Journal of Family PracticeUSPSTF update: Screening for abnormal blood glucose, diabetesJune 29, 2016Diabetes
Family Practice NewsMenopause and cardiovascular risk examined in type 1 diabetesJune 28, 2016CardiologyDiabetesWomen's HealthEndocrinologyPreventive Care
Family Practice NewsWho are the ‘no-shows’ to diabetes education classes?June 28, 2016DiabetesEndocrinology
Family Practice NewsEndoscopic ablation follows gastric bypass principlesJune 27, 2016DiabetesEndocrinologyGastroenterology
Family Practice NewsEmpagliflozin surpasses glimepiride as metformin add-onJune 24, 2016DiabetesEndocrinology
Family Practice NewsLong-haul travel turbulent for many with type 1 diabetesJune 24, 2016DiabetesEndocrinology
Family Practice NewsBariatric surgery good deal for diabetes, but…June 23, 2016DiabetesEndocrinologyObesity
Family Practice NewsBenefits of lifestyle intervention only brief in some patients with type 2 diabetesJune 23, 2016DiabetesObesityEndocrinology
Family Practice NewsLong-term metformin use protective against neurodegenerative diseaseJune 23, 2016DiabetesEndocrinologyNeurology
Family Practice NewsLEADER: Liraglutide lowers CVD risk in type 2 diabetesJune 22, 2016CardiologyDiabetesEndocrinology
Family Practice NewsArtificial pancreas can improve inpatient glycemic control in type 2 diabetesJune 21, 2016DiabetesGeriatricsEndocrinology
